Our aim is to determine the pharmacophore pattern (the essential shape and charge distribution needed for a drug to bind to a receptor) corresponding to the ??7 nicotinic acetylcholine receptors, and hence to develop effective, drug-like modulators of the ??7 receptor that could ameliorate neurological and psychiatric disorders including Alzheimer's and schizophrenia.